Eli Aharoni
Direttore Tecnico/Scientifico/R&S presso SAMSARA VISION, INC.
Posizioni attive di Eli Aharoni
Società | Posizione | Inizio | Fine |
---|---|---|---|
SAMSARA VISION, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2001 | - |
Storia della carriera di Eli Aharoni
Precedenti posizioni note di Eli Aharoni
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACCELERON PHARMA INC. | Direttore Finanziario/CFO | 01/04/2008 | - |
Formazione di Eli Aharoni
Technion-Israel Institute of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Israele | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Samsara Vision, Inc.
Samsara Vision, Inc. Medical SpecialtiesHealth Technology Samsara Vision, Inc. engages in the business of research, development, manufacturing, and marketing proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. It operates under the United States and Other geographical segments. The company was founded by Isaac Lipshitz, David Lifschitz, Yossi Gross, Boaz Lifschitz, and Eyal Lifschitz in 1997 and is headquartered in Far Hills, NJ. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
- Borsa valori
- Insiders
- Eli Aharoni
- Esperienza